Centogene tests the Berliner Philharmoniker

10 Mar 2021

It is not a matter of course in Corona times that the Berliner Philharmoniker are able to perform their concerts in the Digital Concert Hall. The fact that a safe performance is possible even with larger ensembles is thanks to a sponsoring partnership between the Berliner Philharmoniker Foundation and the Rostock biotech company Centogene.

As part of this collaboration, all orchestra musicians are tested twice each week of rehearsals using Centogene’s SARS-CoV-2 RT-PCR test. In addition, protective measures apply at the Philharmonie Berlin, such as the musicians wearing mouth and nose coverings while backstage and until they reach their desks, as well as the thorough cleaning and disinfection of the stage after every rehearsal and concert. The tests, the strict hygiene measures and the extremely well-functioning air-conditioning system in the halls of the Philharmonie Berlin, which is operated with 100% fresh air, have led to the company doctor agreeing to a stage distance of 1 metre between string players and 1.5 metres between wind players.

Centogene AG was founded in 2007 by Arndt Rolfs, professor at Rostock University Medical Center. From the very beginning, the company has worked very closely with the leadership of the University of Rostock and the medical and natural science faculties. After its foundation with only a handful of employees, the company has grown and now has over 220 employees. Centogene AG is known worldwide as a specialist in the characterisation and diagnostics of rare congenital diseases.